nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ORM1—bile—bile duct cancer	0.231	0.346	CbGeAlD
Vismodegib—SHH—pancreas—bile duct cancer	0.0966	0.145	CbGeAlD
Vismodegib—ORM1—gall bladder—bile duct cancer	0.0641	0.096	CbGeAlD
Vismodegib—ALB—gall bladder—bile duct cancer	0.0562	0.0842	CbGeAlD
Vismodegib—SHH—Ectoderm Differentiation—PPFIBP2—bile duct cancer	0.0522	0.188	CbGpPWpGaD
Vismodegib—SMO—liver—bile duct cancer	0.043	0.0644	CbGeAlD
Vismodegib—Etoricoxib—PTGS2—bile duct cancer	0.0351	0.629	CrCbGaD
Vismodegib—SMO—lymph node—bile duct cancer	0.033	0.0494	CbGeAlD
Vismodegib—Sulfasalazine—PTGS2—bile duct cancer	0.0207	0.371	CrCbGaD
Vismodegib—ORM1—liver—bile duct cancer	0.0188	0.0282	CbGeAlD
Vismodegib—ALB—liver—bile duct cancer	0.0165	0.0247	CbGeAlD
Vismodegib—SHH—Heart Development—SMAD4—bile duct cancer	0.0158	0.0571	CbGpPWpGaD
Vismodegib—ORM1—lymph node—bile duct cancer	0.0144	0.0216	CbGeAlD
Vismodegib—SHH—Differentiation Pathway—HGF—bile duct cancer	0.0143	0.0517	CbGpPWpGaD
Vismodegib—CYP2C19—liver—bile duct cancer	0.0133	0.0199	CbGeAlD
Vismodegib—ALB—lymph node—bile duct cancer	0.0126	0.0189	CbGeAlD
Vismodegib—CYP2C8—liver—bile duct cancer	0.0116	0.0173	CbGeAlD
Vismodegib—ABCG2—liver—bile duct cancer	0.0113	0.0169	CbGeAlD
Vismodegib—CYP2C9—liver—bile duct cancer	0.0103	0.0154	CbGeAlD
Vismodegib—SHH—Class B/2 (Secretin family receptors)—GNAS—bile duct cancer	0.00933	0.0337	CbGpPWpGaD
Vismodegib—SMO—Class B/2 (Secretin family receptors)—GNAS—bile duct cancer	0.00885	0.0319	CbGpPWpGaD
Vismodegib—ABCB1—pancreas—bile duct cancer	0.00872	0.0131	CbGeAlD
Vismodegib—ABCG2—lymph node—bile duct cancer	0.00863	0.0129	CbGeAlD
Vismodegib—SHH—Dopaminergic Neurogenesis—TGFB1—bile duct cancer	0.00849	0.0307	CbGpPWpGaD
Vismodegib—SMO—Hedgehog 'off' state—GNAS—bile duct cancer	0.00804	0.029	CbGpPWpGaD
Vismodegib—CYP3A4—liver—bile duct cancer	0.00784	0.0118	CbGeAlD
Vismodegib—SHH—Signaling by Hedgehog—GNAS—bile duct cancer	0.00757	0.0273	CbGpPWpGaD
Vismodegib—SMO—Signaling by Hedgehog—GNAS—bile duct cancer	0.00718	0.0259	CbGpPWpGaD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—bile duct cancer	0.00636	0.023	CbGpPWpGaD
Vismodegib—SHH—Ectoderm Differentiation—SMAD4—bile duct cancer	0.00633	0.0229	CbGpPWpGaD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—bile duct cancer	0.00603	0.0218	CbGpPWpGaD
Vismodegib—SHH—Differentiation Pathway—TGFB1—bile duct cancer	0.00583	0.0211	CbGpPWpGaD
Vismodegib—ABCB1—liver—bile duct cancer	0.00555	0.00832	CbGeAlD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00488	0.0176	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00463	0.0167	CbGpPWpGaD
Vismodegib—SHH—Differentiation Pathway—IL6—bile duct cancer	0.00439	0.0159	CbGpPWpGaD
Vismodegib—ABCB1—lymph node—bile duct cancer	0.00426	0.00638	CbGeAlD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00273	0.00987	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.00272	0.00982	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00267	0.00965	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00259	0.00935	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—GNAS—bile duct cancer	0.00255	0.00922	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00253	0.00915	CbGpPWpGaD
Vismodegib—SHH—Disease—RNF43—bile duct cancer	0.00251	0.00905	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—GNAS—bile duct cancer	0.00242	0.00874	CbGpPWpGaD
Vismodegib—SHH—Disease—IDH1—bile duct cancer	0.00215	0.00778	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.00202	0.00731	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.00193	0.00698	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00189	0.00684	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.00183	0.00661	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.0018	0.00648	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.00179	0.00646	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—RNF43—bile duct cancer	0.00175	0.00634	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.0017	0.00613	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RNF43—bile duct cancer	0.00166	0.00601	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00159	0.00574	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—bile duct cancer	0.00154	0.00557	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00151	0.00544	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.00147	0.00531	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00143	0.00515	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00142	0.00512	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—HGF—bile duct cancer	0.0014	0.00504	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.00133	0.0048	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—GNAS—bile duct cancer	0.00131	0.00473	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00127	0.00459	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—GNAS—bile duct cancer	0.00124	0.00448	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00116	0.00419	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00115	0.00416	CbGpPWpGaD
Vismodegib—SHH—Disease—TGFBR2—bile duct cancer	0.00115	0.00414	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.00109	0.00395	CbGpPWpGaD
Vismodegib—SHH—Disease—SMAD4—bile duct cancer	0.00108	0.00391	CbGpPWpGaD
Vismodegib—CYP2C19—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00103	0.00372	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—FAR2—bile duct cancer	0.00102	0.00369	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000938	0.00339	CbGpPWpGaD
Vismodegib—SHH—Disease—NOS2—bile duct cancer	0.000807	0.00291	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TGFBR2—bile duct cancer	0.000802	0.0029	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—GNAS—bile duct cancer	0.000774	0.00279	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TGFBR2—bile duct cancer	0.00076	0.00275	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SMAD4—bile duct cancer	0.000759	0.00274	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000735	0.00265	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GNAS—bile duct cancer	0.000733	0.00265	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000729	0.00263	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SMAD4—bile duct cancer	0.00072	0.0026	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—FAR2—bile duct cancer	0.000635	0.00229	CbGpPWpGaD
Vismodegib—ALB—Metabolism—FAR2—bile duct cancer	0.000631	0.00228	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000628	0.00227	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.000619	0.00224	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000615	0.00222	CbGpPWpGaD
Vismodegib—SHH—Disease—ERBB2—bile duct cancer	0.000607	0.00219	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000605	0.00218	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000598	0.00216	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000595	0.00215	CbGpPWpGaD
Vismodegib—SHH—Disease—PTGS2—bile duct cancer	0.000593	0.00214	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—TGFB1—bile duct cancer	0.000569	0.00206	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—FAR2—bile duct cancer	0.000567	0.00205	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—FAR2—bile duct cancer	0.000553	0.002	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—NRAS—bile duct cancer	0.000547	0.00198	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—bile duct cancer	0.000546	0.00197	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.000542	0.00196	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000534	0.00193	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—NRAS—bile duct cancer	0.000519	0.00187	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—FAR2—bile duct cancer	0.000517	0.00187	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	0.000504	0.00182	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL6—bile duct cancer	0.0005	0.00181	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—IDH2—bile duct cancer	0.000499	0.0018	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EGFR—bile duct cancer	0.000499	0.0018	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000487	0.00176	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EGFR—bile duct cancer	0.000473	0.00171	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—KRAS—bile duct cancer	0.000471	0.0017	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00047	0.0017	CbGpPWpGaD
Vismodegib—SHH—Disease—NRAS—bile duct cancer	0.000462	0.00167	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—KRAS—bile duct cancer	0.000446	0.00161	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—IDH1—bile duct cancer	0.000429	0.00155	CbGpPWpGaD
Vismodegib—SHH—Disease—TGFB1—bile duct cancer	0.000429	0.00155	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ERBB2—bile duct cancer	0.000425	0.00153	CbGpPWpGaD
Vismodegib—SHH—Disease—EGFR—bile duct cancer	0.000421	0.00152	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ERBB2—bile duct cancer	0.000403	0.00145	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HRAS—bile duct cancer	0.0004	0.00145	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	0.000397	0.00143	CbGpPWpGaD
Vismodegib—SHH—Disease—KRAS—bile duct cancer	0.000397	0.00143	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL6—bile duct cancer	0.000383	0.00138	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HRAS—bile duct cancer	0.000379	0.00137	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000373	0.00135	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MMP9—bile duct cancer	0.000364	0.00132	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL6—bile duct cancer	0.000363	0.00131	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000352	0.00127	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MMP9—bile duct cancer	0.000345	0.00125	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.000344	0.00124	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—FAR2—bile duct cancer	0.000341	0.00123	CbGpPWpGaD
Vismodegib—SHH—Disease—HRAS—bile duct cancer	0.000338	0.00122	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—GNAS—bile duct cancer	0.000335	0.00121	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000327	0.00118	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NRAS—bile duct cancer	0.000323	0.00117	CbGpPWpGaD
Vismodegib—SHH—Disease—IL6—bile duct cancer	0.000323	0.00117	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HGF—bile duct cancer	0.000319	0.00115	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—IDH2—bile duct cancer	0.00031	0.00112	CbGpPWpGaD
Vismodegib—ALB—Metabolism—IDH2—bile duct cancer	0.000308	0.00111	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NRAS—bile duct cancer	0.000306	0.00111	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TGFB1—bile duct cancer	0.0003	0.00108	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EGFR—bile duct cancer	0.000295	0.00106	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00029	0.00105	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TGFB1—bile duct cancer	0.000285	0.00103	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC5A5—bile duct cancer	0.000283	0.00102	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EGFR—bile duct cancer	0.000279	0.00101	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—KRAS—bile duct cancer	0.000278	0.001	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—IDH2—bile duct cancer	0.000277	0.000999	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—IDH2—bile duct cancer	0.00027	0.000975	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—IDH1—bile duct cancer	0.000267	0.000963	CbGpPWpGaD
Vismodegib—ALB—Metabolism—IDH1—bile duct cancer	0.000265	0.000957	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—KRAS—bile duct cancer	0.000264	0.000952	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000254	0.000918	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000252	0.000912	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—IDH2—bile duct cancer	0.000252	0.000911	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000249	0.000898	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—bile duct cancer	0.000247	0.000893	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NOS2—bile duct cancer	0.000245	0.000884	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000244	0.00088	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—IDH1—bile duct cancer	0.000238	0.000859	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HRAS—bile duct cancer	0.000236	0.000854	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—bile duct cancer	0.000234	0.000847	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—IDH1—bile duct cancer	0.000232	0.000839	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.00023	0.000831	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—bile duct cancer	0.000226	0.000817	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HRAS—bile duct cancer	0.000224	0.00081	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GNAS—bile duct cancer	0.00022	0.000795	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—IDH1—bile duct cancer	0.000217	0.000783	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—bile duct cancer	0.000215	0.000775	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000205	0.000739	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC5A5—bile duct cancer	0.000176	0.000635	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC5A5—bile duct cancer	0.000175	0.000631	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—IDH2—bile duct cancer	0.000166	0.000601	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000165	0.000595	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000164	0.000592	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC5A5—bile duct cancer	0.000157	0.000567	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC5A5—bile duct cancer	0.000153	0.000553	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000147	0.000531	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC5A5—bile duct cancer	0.000143	0.000517	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000143	0.000517	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NRAS—bile duct cancer	0.00014	0.000506	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GNAS—bile duct cancer	0.000137	0.000493	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GNAS—bile duct cancer	0.000136	0.000491	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000134	0.000484	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—bile duct cancer	0.00013	0.00047	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GNAS—bile duct cancer	0.000122	0.00044	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KRAS—bile duct cancer	0.000121	0.000435	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GNAS—bile duct cancer	0.000119	0.00043	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—bile duct cancer	0.000118	0.000427	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GNAS—bile duct cancer	0.000111	0.000402	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—bile duct cancer	0.000107	0.000387	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—bile duct cancer	0.000102	0.00037	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC5A5—bile duct cancer	9.44e-05	0.000341	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—bile duct cancer	7.34e-05	0.000265	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GNAS—bile duct cancer	7.33e-05	0.000265	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—bile duct cancer	7.3e-05	0.000264	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—bile duct cancer	6.55e-05	0.000237	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—bile duct cancer	6.39e-05	0.000231	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—bile duct cancer	5.97e-05	0.000216	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—bile duct cancer	3.94e-05	0.000142	CbGpPWpGaD
